These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 864907)

  • 1. [Aldosteronemia and plasma renin activity in patients with hypertension treated with visken (prindolol)].
    Kuska J; Kokot F; Sledziński Z
    Kardiol Pol; 1977; 20(2):127-35. PubMed ID: 864907
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
    Werning C; Vetter H
    Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of prindolol on the blood-pressure profile of hypertensives (with special consideration of response to exercise and plasma-renin activity) (author's transl)].
    Dufey K; Krönig B; Fries G; Gunkel R; Walter U; Wolff HP
    Dtsch Med Wochenschr; 1975 Aug; 100(35):1726-30. PubMed ID: 1157670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the beta-receptor blocking agent visken on blood pressure of hypertensive patients, on plasma renin activity and electrolytes.
    Sonkodi S; Pap A; Varró V
    Ther Hung; 1976; 24(2):60-2. PubMed ID: 982340
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lowering of the blood pressure and renin suppression by beta receptor blockade with Visken in patients with borderline hypertension (author's transl)].
    Werning C
    Med Klin; 1973 Nov; 68(47):1559-63. PubMed ID: 4781097
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency].
    De Ferrari G; Gaiter A; Ginevri F; Tizianello A
    Clin Ter; 1979 Sep; 90(5):461-8. PubMed ID: 399210
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of prindolol on plasma noradrenaline, plasma renin and sodium-potassium metabolism in patients with essential hypertension.
    Brecht HM; Werner E; Schoeppe W
    Adv Clin Pharmacol; 1976; 11():66-9. PubMed ID: 1032572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pindolol and propranolol on plasma renin and aldosterone in patients with renal allograft.
    Wehling M; Kuhlmann U; Záruba K; Largiadèr F; Keusch G; Studer A; Vetter W
    Clin Nephrol; 1983 Nov; 20(5):231-4. PubMed ID: 6360452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function, body fluid volumes, renin, aldosterone, and noradrenaline during treatment of hypertension with pindolol.
    Wilcox CS; Lewis PS; Peart WS; Sever PS; Osikowska BA; Suddle SA; Bluhm MM; Veall N; Lancaster R
    J Cardiovasc Pharmacol; 1981; 3(3):598-611. PubMed ID: 6168840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Essential hypertension with low levels of plasma renin activity: effects of propranolol on aldosteronemia, plasma volume and electrolyte balance].
    Santucci A; Aguglia F; de Mattia G; Gnecchi M; Cicconetti P; Federico M
    Clin Ter; 1980 Aug; 94(4):375-82. PubMed ID: 7006886
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute and chronic beta-receptor blockade: influence on blood pressure and on the renin-angiotensin-aldosterone system in essential hypertension].
    Stumpe KO; Kolloch R; Gramann W; Vetter H; Krück F
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1325-8. PubMed ID: 1029991
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of visken and hypothiazide on the indices of the central and renal hemodynamics in patients with atherosclerotic hypertension].
    Shishkina OS
    Vrach Delo; 1990 Apr; (4):41-3. PubMed ID: 2275163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of Prindolol on intra-arterial pressure and plasma renin activity in essential hypertension].
    Oster P; Matthes D; Hüllemann KD
    Med Welt; 1976 Dec; 27(50):2435-7. PubMed ID: 1011973
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sodium outflow rate through lymphocyte cell membranes, serum levels of sodium, potassium, aldosterone, total catecholamines, 6-keto- PGF2alpha and plasma renin activity in patients with primary arterial hypertension treated with captopril].
    Mazurek W; Halawa B; Borejko-Słopecka G
    Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):588-93. PubMed ID: 1488334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood pressure and renin activity in essential hypertension under pindolol].
    Nussberger J; Vetter W; Furrer J; Beckerhoff R; Würsten D; Schmied U; Siegenthaler W
    Schweiz Med Wochenschr; 1976 Jun; 106(24):831-4. PubMed ID: 996500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension].
    Savenkov PM; Doshitsin VL; Grudtsyn GV
    Kardiologiia; 1977 Oct; 17(10):62-6. PubMed ID: 599799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pindolol on plasma renin activity in patients with essential hypertension.
    Tényi I; Németh M; Jávor T; Nemes J; Czimer J
    Eur J Clin Invest; 1977 Oct; 7(5):325-9. PubMed ID: 411662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma renin activity, aldosterone and cortisol levels during physical exercise in essential hypertension.
    Ignatowska-Switalska H; Wocial B; Skórka B; Chodakowska J; Nazar K; Chwalbińska-Moneta J
    Acta Physiol Pol; 1980; 31(6):631-5. PubMed ID: 7018172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of total body potassium and decrease of exchangeable sodium after long-term treatment with a beta-receptor-blocking agent (prindolol) in essential hypertension.
    Brecht HM; Werner E; Schoeppe W
    Clin Sci Mol Med Suppl; 1976 Dec; 3():551s-554s. PubMed ID: 1071679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma renin activity and plasma aldosterone in essential hypertension: effect of age and diastolic blood pressure].
    Vetter H; Alasso I; Appenheimer M; Weiand H; Stelkens H; Lucas R; Glänzer K; Witassek F; Stumpe KO; Trübestein G; Krück F
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1729-32. PubMed ID: 1013695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.